Blossom Health, a telepsychiatry startup based in New York and established in 2024, has successfully raised $20 million through seed and Series A funding rounds. The investment will be used to expand its AI-driven platform that integrates clinical copilots and automated administrative tools to assist psychiatrists. Leading the funding round was Headline, with its co-founder and managing partner Mathias Schilling joining Blossom Health’s board.
Back
